Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

Koios DS review

#44 of 54 in Medical Imaging Analytics Software

A focused choice for ultrasound lesion assessment, not broad imaging analytics.

4.5/10Editor score
Koios DS4.5 Visit Koios DS

Reviewed by iTechGuides Editors · Editorial team · Updated Nov 2026

For interpreting physicians and sonographers assessing suspicious breast and thyroid lesions, Koios DS brings AI-assisted decision support into ultrasound interpretation. Clinicians select a region of interest, and the software analyzes image features to produce a cancer-risk assessment and associated descriptors. Its focused scope suits mid-market and enterprise practices seeking support for these examinations rather than a general imaging analytics system. Koios DS is an adjunct to clinical diagnosis, not a replacement for it, and its FDA clearance covers adjunctive analysis of suspicious breast or thyroid ultrasound lesions.

The central capability pairs lesion assessment with automatic nodule descriptor capture and BI-RADS or ATA-aligned ratings. That combination connects the image analysis to the terminology used to characterize findings, rather than stopping at a risk assessment alone. Breast ultrasound cancer-risk assessment and thyroid nodule analysis are the core applications. Practices choosing it should want that specific decision-support function: Koios DS does not provide triage prioritization, segmentation and quantification, cardiac analytics, or pathology analysis. A department seeking those capabilities should choose a broader or differently specialized imaging product instead.

Workflow fit is another important consideration. Koios DS integrates with PACS workstations and the GE Healthcare LOGIQ E10 ultrasound scanner, exports findings to reporting systems, and saves secondary captures to PACS. These connections make it relevant to practices that want assessment results carried into their existing image-review and reporting workflows. Deployment is self-hosted and on premises, so it fits organizations prepared to operate software within that environment rather than those seeking a hosted service.

Koios DS pros and cons

  • Where it wins
    • AI cancer-risk assessment with BI-RADS and ATA-aligned ratings
    • Automatic nodule descriptor capture and reporting-system export
    • PACS workstation integration and secondary-capture saving
  • Where it doesn't
    • Limited to breast and thyroid ultrasound assessment
    • No triage prioritization or segmentation and quantification
    • Self-hosted deployment only; no free plan

Koios DS fact sheet, pricing and score →

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Last updated · How we research and update